Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA1A | P35348 | 4/20 | 0.50 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.42 |
| ▸ | DRD2 | P14416 | 1/20 | 0.41 |
| ▸ | DRD3 | P35462 | 1/20 | 0.41 |
| ▸ | HTR2A | P28223 | 2/20 | 0.41 |
| ▸ | HTR2C | P28335 | 2/20 | 0.41 |
| ▸ | HTR2B | P41595 | 1/20 | 0.41 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | KDM1A | O60341 | 1/20 | 0.37 |
| ▸ | MAOA | P21397 | 1/20 | 0.37 |
| ▸ | HTR1A | P08908 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6745026 | 0.81 | HTR2C (0.51) | HTR2AHTR2CHTR2BHSD11B1MEN1 | |
| SCHEMBL17356793 | 0.80 | ABCB1 (0.43) | ADRA1AABCB1DRD2HSD11B1CA1 | |
| SCHEMBL1643779 | 0.77 | HTR2C (0.51) | HTR2AHTR2CHTR2BHSD11B1MEN1 | |
| SCHEMBL1643778 | 0.77 | HTR2C (0.51) | HTR2AHTR2CHTR2BHSD11B1MEN1 | |
| SCHEMBL8439755 | 0.74 | HTR2A (0.47) | HTR2AHTR2CHTR2BHSD11B1 | |
| SCHEMBL17356807 | 0.72 | HTR1A (0.40) | ADRA1AABCB1DRD2HSD11B1CA1 | |
| SCHEMBL17356810 | 0.72 | ADRA1A (0.42) | ADRA1AABCB1DRD2CA1CA2 | |
| SCHEMBL6273883 | 0.71 | ADRA1A (0.58) | ADRA1AHTR2AHTR2CHTR2BKDM1A | |
| SCHEMBL10263051 | 0.71 | HTR2C (0.55) | DRD2HTR2AHTR2CHTR2BKDM1A | |
| SCHEMBL4259949 | 0.71 | HTR2C (0.55) | DRD2HTR2AHTR2CHTR2BKDM1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3107898-B1 | 1,2-SUBSTITUTED CYCLOPENTANES AS OREXIN RECEPTOR ANTAGONISTS | TAKEDA PHARMACEUTICALS CO (JP) | 2021-01-06 | — | — | EP | disclosed |